Fortis Hospital Bannerghatta Road successfully implanted two hearing devices simultaneously in a single procedure on a 23-year-old Nigerian woman with profound hearing loss. Under the expert care of Dr. H K Susheen Dutt, Senior Consultant – ENT, Cochlear implant, and skull base surgeon, Fortis Hospital, Bannerghatta Road the complex procedure was completed in 9 hours.
The patient was discharged 5 days post-surgery and is currently undergoing auditory verbal training in Nigeria with positive results. Patient Lina (name changed) led a normal, joyful life until 2020, when she experienced a viral fever episode that resulted in hearing loss in her right ear, followed by her left ear, ultimately leading to profound hearing loss in both ears.
The hearing impairment was so severe that she struggled to perform daily tasks and lead a normal life. Recognizing the severity of her condition, she travelled from Nigeria with her family to seek expert medical advice and care at Fortis Hospital Bannerghatta, Bengaluru.
Upon thorough evaluation, she was diagnosed with Bilateral Profound Sensory Neural Hearing Loss caused by damage to the inner ear, resulting in severe hearing loss in both ears, rendering her unable to hear even the loudest of sounds. Given the seriousness of her condition, the team of doctors proposed Simultaneous Bilateral Cochlear Implantation Surgery as the best course of action. This involved the placement of two implantable hearing devices simultaneously in a single surgical session.
Dr H K Susheen Dutt, Senior Consultant – ENT Specialist, Cochlear implant and skull base surgeon, Fortis Hospital, Bannerghatta Road, said, “While high-gain hearing aids are often effective for severe hearing loss cases, Lina's condition surpassed the capabilities of even the most advanced devices. Despite attempting various high-gain aids, no significant improvement was noted.
Her strong desire for improved hearing, coupled with her recent normal hearing history, indicated potential success with cochlear implant surgery. We discussed the procedure with her family, emphasizing the promising outcomes and gaining their consent for bilateral surgery. Typically, cochlear implantation is done in one ear at a time, but we opted for simultaneous bilateral implants for Lina due to the advantages they offer: a more natural hearing experience, enhanced sound localization, and improved speech comprehension, especially in noisy environments.
This approach also minimized the need for multiple surgeries, considering the considerable travel and logistical challenges involved. Three weeks post-surgery, Lina's cochlear implants were activated.” She is currently undergoing auditory verbal training in Nigeria, showing remarkable progress.
Her previous experience with normal hearing facilitates her rehabilitation, making the training more effective and her adjustment smoother. Cochlear implantation is a highly safe procedure, boasting a success rate exceeding 98% for suitable candidates like Lina.
Mr. Akshay Oleti, Business Head, Fortis Hospitals Bengaluru, added, “With our hospital’s expertise in advanced medical procedures and our team's dedication to excellence, this successful surgery symbolizes our commitment to providing transformative healthcare experiences for patients seeking medical advice from anywhere in the world.
We are honoured to have played a part in restoring Lina's ability to hear and communicate. Her story serves as a beacon of hope for all facing similar challenges. At Fortis Bannerghatta, we remain dedicated to empowering lives through compassionate care and the expertise by our highly skilled experts.”
About Fortis Healthcare Limited
Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 28 healthcare facilities, 4,500+ operational beds (including O&M facilities) and over 400 diagnostics centers (including JVs).
Fortis is present in India, United Arab Emirates (UAE), Nepal & Sri Lanka. The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with global major and parent company - IHH, to build upon its culture of world-class patient care and superlative clinical excellence.
Fortis employs ~23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.